Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical relevance of brain atrophy subtypes categorization in memory clinics.
Planche V, Bouteloup V, Mangin JF, Dubois B, Delrieu J, Pasquier F, Blanc F, Paquet C, Hanon O, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Habert MO, Fischer C, Chupin M, Béjot Y, Godefroy O, Wallon D, Sauvée M, Bourdel-Marchasson I, Jalenques I, Tison F, Chêne G, Dufouil C; the MEMENTO Study group.. Planche V, et al. Among authors: ceccaldi m. Alzheimers Dement. 2021 Apr;17(4):641-652. doi: 10.1002/alz.12231. Epub 2020 Dec 15. Alzheimers Dement. 2021. PMID: 33325121
Telemedicine in French Memory Clinics During the COVID-19 Pandemic.
Morin A, Pressat-Laffouilhere T, Sarazin M, Lagarde J, Roue-Jagot C, Olivieri P, Paquet C, Cognat E, Dumurgier J, Pasquier F, Lebouvier T, Ceccaldi M, Godefroy O, Martinaud O, Grosjean J, Zarea A, Maltête D, Wallon D. Morin A, et al. Among authors: ceccaldi m. J Alzheimers Dis. 2022;86(2):525-530. doi: 10.3233/JAD-215459. J Alzheimers Dis. 2022. PMID: 34974434
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.
Nicolas G, Zaréa A, Lacour M, Quenez O, Rousseau S, Richard AC, Bonnevalle A, Schramm C, Olaso R, Sandron F, Boland A, Deleuze JF, Andriuta D, Anthony P, Auriacombe S, Balageas AC, Ballan G, Barbay M, Béjot Y, Belliard S, Benaiteau M, Bennys K, Bombois S, Boutoleau-Bretonnière C, Branger P, Carlier J, Cartz-Piver L, Cassagnaud P, Ceccaldi MP, Chauviré V, Chen Y, Cogez J, Cognat E, Contegal-Callier F, Corneille L, Couratier P, Cretin B, Crinquette C, Dauriat B, Dautricourt S, de la Sayette V, de Liège A, Deffond D, Demurger F, Deramecourt V, Derollez C, Dionet E, Doco Fenzy M, Dumurgier J, Dutray A, Etcharry-Bouyx F, Formaglio M, Gabelle A, Gainche-Salmon A, Godefroy O, Graber M, Gregoire C, Grimaldi S, Gueniat J, Gueriot C, Guillet-Pichon V, Haffen S, Hanta CR, Hardy C, Hautecloque G, Heitz C, Hourregue C, Jonveaux T, Jurici S, Koric L, Krolak-Salmon P, Lagarde J, Lanoiselée HM, Laurens B, Le Ber I, Le Guyader G, Leblanc A, Lebouvier T, Levy R, Lippi A, Mackowiak MA, Magnin E, Marelli C, Martinaud O, Maureille A, Migliaccio R, Milongo-Rigal E, Mohr S, Mollion H, Morin A, Nivelle J, Noiray C, Olivieri P, Paquet C, Pariente J, Pasquier F, Perron A, Philippi N, Planche V, Pouc… See abstract for full author list ➔ Nicolas G, et al. Among authors: ceccaldi mp. Genet Med. 2024 May;26(5):101082. doi: 10.1016/j.gim.2024.101082. Epub 2024 Jan 24. Genet Med. 2024. PMID: 38281098 Free article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet.
Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, Sanabria Bohorquez SM, Anania VG, Wildsmith KR, Schauer SP, Lee J, Dolton MJ, Ramakrishnan V, Abramzon D, Teng E; Lauriet investigators. Monteiro C, et al. Neurology. 2023 Oct 3;101(14):e1391-e1401. doi: 10.1212/WNL.0000000000207663. Epub 2023 Aug 29. Neurology. 2023. PMID: 37643887 Free PMC article. Clinical Trial.
Brain FDG-PET correlates of saccadic disorders in early PSP.
Pin G, Labouré J, Guedj E, Felician O, Grimaldi S, Azulay JP, Ceccaldi M, Koric L. Pin G, et al. Among authors: ceccaldi m. J Neurol. 2023 Oct;270(10):4841-4850. doi: 10.1007/s00415-023-11824-w. Epub 2023 Jun 18. J Neurol. 2023. PMID: 37330976
Daisy-shaped liquid bridges in foam-filled granular packings.
Pitois O, Salamé A, Khidas Y, Ceccaldi M, Langlois V, Vincent-Bonnieu S. Pitois O, et al. Among authors: ceccaldi m. J Colloid Interface Sci. 2023 May 15;638:552-560. doi: 10.1016/j.jcis.2023.01.127. Epub 2023 Jan 30. J Colloid Interface Sci. 2023. PMID: 36773517
Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort.
Lespinasse J, Chêne G, Mangin JF, Dubois B, Blanc F, Paquet C, Hanon O, Planche V, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Godefroy O, Wallon D, Sauvée M, Bergeret S, Chupin M, Proust-Lima C, Dufouil C; MEMENTO study group. Lespinasse J, et al. Among authors: ceccaldi m. Alzheimers Dement. 2023 Jun;19(6):2332-2342. doi: 10.1002/alz.12866. Epub 2022 Dec 4. Alzheimers Dement. 2023. PMID: 36464896
160 results